SCOPUS 정보 검색 플랫폼

Journal of Clinical Oncology

Volumn 29, Issue 10, 2011, Pages

Pyoderma gangrenosum with the use of sunitinib

(3) Nadauld, Lincoln D a Miller, Martin B b Srinivas, Sandy a

a STANFORD UNIVERSITY SCHOOL OF MEDICINE (United States)

b UNIVERSITY OF CALIFORNIA (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; PREDNISONE; SUNITINIB;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DEEP VEIN THROMBOSIS; DRUG MEGADOSE; DRUG WITHDRAWAL; ERYTHEMA; FEMORAL VEIN; GASTROINTESTINAL STROMAL TUMOR; HISTOLOGY; HUMAN; INFERIOR CAVA VEIN; KIDNEY CARCINOMA; LEG DISEASE; LEG PAIN; LEG ULCER; MALE; NEPHRECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; SWELLING; TUMOR GROWTH; ULTRASOUND;

ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; BIOPSY; CARCINOMA, RENAL CELL; CHEMOTHERAPY, ADJUVANT; HUMANS; INDOLES; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEPHRECTOMY; PREDNISONE; PROTEIN KINASE INHIBITORS; PYODERMA GANGRENOSUM; PYRROLES; SKIN; TREATMENT OUTCOME;

EID: 79954434238 PISSN: 0732183X EISSN: 15277755 Source Type: Journal
DOI: 10.1200/JCO.2010.32.6165 Document Type: Article

Times cited : (14)

References (10)

1
- 0029958881
- Pyoderma gangrenosum: Classification and management
- DOI 10.1016/S0190-9622(96)90428-4
- Powell FC, Su WP, Perry HO: Pyoderma gangrenosum: Classification and management. J Am Acad Dermatol 34:395-409, 1996 (Pubitemid 26083814)
- (1996) Journal of the American Academy of Dermatology , vol.34 , Issue.3 , pp. 395-409
- Powell, F.C.¹ Su, W.P.D.² Perry, H.O.³

2
- 77749264527
- Pyoderma gangrenosum: A review and update on new therapies
- Miller J, Yentzer BA, Clark A, et al: Pyoderma gangrenosum: A review and update on new therapies. J Am Acad Dermatol 62:646-654, 2010
- (2010) J. Am. Acad. Dermatol. , vol.62 , pp. 646-654
- Miller, J.¹ Yentzer, B.A.² Clark, A.³

3
- 76449094050
- Understanding the molecular-based mechanism of action of the tyrosine kinase inhibitor: Sunitinib
- suppl 1
- Mena AC, Pulido EG, Guillen-Ponce C: Understanding the molecular-based mechanism of action of the tyrosine kinase inhibitor: Sunitinib. Anticancer Drugs 21: S3-11, 2010 (suppl 1)
- (2010) Anticancer Drugs , vol.21
- Mena, A.C.¹ Pulido, E.G.² Guillen-Ponce, C.³

4
- 12244301581
- In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: Determination of a pharmacokinetic/pharmacodynamic relationship
- Mendel DB, Laird AD, Xin X, et al: In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: Determination of a pharmacokinetic/pharmacodynamic relationship. Clin Cancer Res 9:327-337, 2003 (Pubitemid 36109749)
- (2003) Clinical Cancer Research , vol.9 , Issue.1 , pp. 327-337
- Mendel, D.B.¹ Douglas Laird, A.² Xin, X.³ Louie, S.G.⁴ Christensen, J.G.⁵ Li, G.⁶ Schreck, R.E.⁷ Abrams, T.J.⁸ Ngai, T.J.⁹ Lee, L.B.¹⁰ Murray, L.J.¹¹ Carver, J.¹² Chan, E.¹³ Moss, K.G.¹⁴ Haznedar, J.O.¹⁵ Sukbuntherng, J.¹⁶ Blake, R.A.¹⁷ Sun, L.¹⁸ Tang, C.¹⁹ Miller, T.²⁰ more..

5
- 33846181370
- Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
- DOI 10.1056/NEJMoa065044
- Motzer RJ, Hutson TE, Tomczak P, et al: Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 356:115-124, 2007 (Pubitemid 46089672)
- (2007) New England Journal of Medicine , vol.356 , Issue.2 , pp. 115-124
- Motzer, R.J.¹ Hutson, T.E.² Tomczak, P.³ Michaelson, D.⁴ Bukowski, R.M.⁵ Rixe, O.⁶ Oudard, S.⁷ Negrier, S.⁸ Szczylik, C.⁹ Kim, S.T.¹⁰ Chen, I.¹¹ Bycott, P.W.¹² Baum, C.M.¹³ Figlin, R.A.¹⁴

6
- 33947504730
- Sunitinib: From rational design to clinical efficacy
- DOI 10.1200/JCO.2006.06.3602
- Chow LQ, Eckhardt SG: Sunitinib: From rational design to clinical efficacy. J Clin Oncol 25:884-896, 2007 (Pubitemid 350002890)
- (2007) Journal of Clinical Oncology , vol.25 , Issue.7 , pp. 884-896
- Chow, L.Q.M.¹ Eckhardt, S.G.²

7
- 45749118676
- Pyoderma gangrenosum: Another cutaneous side-effect of sunitinib?
- DOI 10.1111/j.1365-2133.2008.08599.x
- ten Freyhaus K, Homey B, Bieber T, et al: Pyoderma gangrenosum: Another cutaneous side-effect of sunitinib? Br J Dermatol 159:242-243, 2008 (Pubitemid 351874484)
- (2008) British Journal of Dermatology , vol.159 , Issue.1 , pp. 242-243
- Ten Freyhaus, K.¹ Homey, B.² Bieber, T.³ Wilsmann-Theis, D.⁴

8
- 10644269924
- Neutrophilic eccrine hidradenitis induced by imatinib mesylate (Gleevec) therapy [1]
- DOI 10.1016/j.leukres.2004.05.015, PII S014521260400222X
- Dib EG, Ifthikharuddin JJ, Scott GA, et al: Neutrophilic eccrine hidradenitis induced by imatinib mesylate (Gleevec) therapy. Leuk Res 29:233-234, 2005 (Pubitemid 39647519)
- (2005) Leukemia Research , vol.29 , Issue.2 , pp. 233-234
- Dib, E.G.¹ Ifthikharuddin, J.J.² Scott, G.A.³ Partilo, S.R.⁴

9
- 33744537616
- Imatinib mesylate and dermatology part 2: A review of the cutaneous side effects of imatinib mesylate
- Scheinfeld N: Imatinib mesylate and dermatology part 2: A review of the cutaneous side effects of imatinib mesylate. J Drugs Dermatol 5:228-231, 2006
- (2006) J. Drugs Dermatol. , vol.5 , pp. 228-231
- Scheinfeld, N.¹

10
- 0021352266
- Acute neutrophilic dermatosis with diffuse histiocytic lymphoma
- Schwartz RA, French SW, Rubenstein DJ, et al: Acute neutrophilic dermatosis with diffuse histiocytic lymphoma. J Am Acad Dermatol 10:350-354, 1984 (Pubitemid 14181963)
- (1984) Journal of the American Academy of Dermatology , vol.10 , Issue.2 SUPPL. , pp. 350-354
- Schwartz, R.A.¹ French, S.W.² Rubenstein, D.J.³ Lambert, W.C.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.